Abstract
A remotely operated, shielded synthesis system for the production of 2-deoxy-2-[ 18F]fluoro-D-glucose ( 18FDG) for clinical studies has been developed. Using this system, 25 mCi of 18FDG are produced at the end of a 60-min synthesis from ~300 mCi of F-18 (total F-18 among various components of the synthesis system has been measured. This yield of 18FDG (25 mCi) is ample for two consecutive human studies in house or for shipment to collaborating institutions within a 3-hr (door to door) radius.
Original language | English |
---|---|
Pages (from-to) | 376-380 |
Number of pages | 5 |
Journal | Journal of Nuclear Medicine |
Volume | 22 |
Issue number | 4 |
State | Published - 1981 |
Externally published | Yes |